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Abstract
Previous studies showed that g-linolenic acid (GLA, 18: 3 ω-6), arachidonic acid (AA, 20:4 ω -6), eicosapentaenoic
acid (EPA, 20: 5 ω -3) and docosahexaenoic acid (DHA, 22:6 ω -3) have selective tumoricidal action. In the present
study, it was observed that dihomo-gamma-linolenic acid (DGLA) and AA, EPA and DHA have cytotoxic action on
both vincristine-sensitive (KB-3-1) and resistant (KB-Ch
R-8-5) cancer cells in vitro that appeared to be a free-radical
dependent process but not due to the formation of prostaglandins, leukotrienes and thromboxanes. Uptake of
vincristine and fatty acids was higher while their efflux was lower in KB-3-1 cells compared with KB-Ch
R-8-5 cells,
suggesting that drug resistant cells have an effective efflux pump. GLA, DGLA, AA, EPA and DHA enhanced the
uptake and decreased efflux in both drug-sensitive and drug-resistant cells and augmented the susceptibility of
tumor cells especially, of drug-resistant cells to the cytotoxic action of vincristine. These results suggest that certain
polyunsaturated fatty acids have tumoricidal action and are capable of enhancing the cytotoxic action of anti-
cancer drugs specifically, on drug-resistant cells by enhancing drug uptake and reducing its efflux. Thus,
polyunsaturated fatty acids either by themselves or in combination with chemotherapeutic drugs have the
potential as anti-cancer molecules.
Keywords: Polyunsaturated fatty acids, essential fatty acids, free radicals, vincristine, lipid peroxidation, cancer,
uptake, efflux, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, gamma-linolenic acid, linoleic acid,
linolenic acid
Introduction
It is desirable to kill tumor cells selectively without
harming normal cells. But, currently available drugs and
radiation fail to kill only tumor cells and cause signifi-
cant side effects that are undesirable. Anti-VEGF (vascu-
lar endothelial growth factor) and anti-EGF (epidermal
growth factor) and other monoclonal antibodies devel-
oped for use in cancer do possess some degree of speci-
fic action on tumor cells yet are not very effective. In
view of this, further studies are needed to identify newer
molecules that possess selective tumoricidal property
that are less toxic but have predictable actions.
Previously, we and others showed that some polyunsa-
turated fatty acids (PUFAs) induced apoptosis of tumor
cells with little or no cytotoxic action on normal cells
under the conditions employed [1-10]. It was observed
that of all the fatty acids tested, GLA was the most
effective in selectively killing the tumor cells. In a co-
culture experiment wherein normal human skin fibro-
blasts (CCD-41-SK) and human breast cancer cells (ZR-
75-1) were grown together in a petri dish and supple-
mented with GLA, only human breast cancer cells were
eliminated without any effect on normal skin fibroblasts
[11]. These results reconfirmed that GLA and possibly,
other PUFAs under some specific conditions show selec-
tive tumoricidal action at least in vitro. GLA and other
unsaturated other fatty acids induced apoptosis of
tumor cells by enhancing the release of cytochrome c,
activating caspase-3, suppressing Akt phosphorylation
and modulating p38 MAPK in the phosphorylation of
p53 at Ser15, a site which is associated with DNA
damage (9, 10). These molecular changes were found to
be significantly associated with enhanced degree of lipid
peroxidation in the fatty acid supplemented tumor cells
(1-5, 9). GLA and other PUFAs were also found to be
capable of suppressing the expression of oncogenes ras
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apoptosis of tumor cells [12].
In an extension of these studies, it was noted that
cyclo-oxygenase (CO) and lipoxygenase (LO) inhibitors
blocked the tumoricidal action of GLA on human cervi-
cal carcinoma, HeLa cells; whereas anti-oxidants inhib-
ited cytotoxic action of GLA on human breast cancer,
ZR-75-1, cells [1,2,4]. Prostaglandins (PGE1,P G E 2,
PGF2a,P G I 2) and LO products of GLA: 13-HPODE and
6-HPODE, inhibited the growth of HeLa cells [2,4]. LO
products were more potent than PGs in inhibiting of
HeLa cell growth [4] that was confirmed by the observa-
tion that a 9-fold increased formation of hydroxides
occurred in HeLa cells treated with GLA. These results
suggest that both CO and LO products and free radicals
are involved in the tumoricidal action of GLA. A signifi-
cant increase in the formation of free radicals and lipid
peroxides was noted only in tumor cells treated with
GLA (GLA > AA > EPA > LA) compared to untreated
tumor cells or GLA-treated normal skin fibroblasts
[1,4,5,9,13,14], suggesting that the involvement of CO
and LO products, free radicals and lipid peroxides in
the tumoricidal action of GLA and PUFAs varies
depending on the cell type that is being tested.
Drug resistance is a major issue in the management of
cancer. Hence, methods or strategies to prevent and/or
reverse tumor cell dug resistance are needed. Previously,
we observed that GLA could kill even drug resistant
tumor cells in vitro [15]. GLA augmented the cytotoxic
action of anti-cancer drugs cis-platinum and doxorubi-
cin [16]. Studies by Menendez et al [17], Hernandez et
al [18], and Rudra et al [19] confirmed that GLA and
other unsaturated fatty acids augment tumoricidal
actions of anti-cancer drugs and a synergism exists
between conventional anti-cancer drugs and GLA. But,
it is not clear as to the exact mechanism by which this
synergism between anti-cancer drugs and fatty acids
occurs. In the present study, we studied the effects of
various PUFAs on drug-sensitive and drug-resistant
tumor cells, possible potentiation of the tumoricidal
action of sub-optimal anti-cancer drugs on drug-resis-
tant cells and possible mechanisms(s) involved in these
actions.
Materials and methods
Cells and culture conditions
Human cervical carcinoma cells which are sensitive (KB-
3-1) and resistant (KB-Ch
R-8-5) to the cytotoxic action
of vincristine respectively were used for this study. KB-
3-1 and KB-Ch
R-8-5 are HeLa variant cell lines.
These cells were grown and maintained in NUNC cul-
ture flasks in bicarbonate buffered DMEM with 10%
fetal calf serum and L-glutamine at 37°C in a 5% CO2
humidified incubator. KB-Ch
R-8-5 cells, which are 4-
fold resistant to colchicine, were grown in the continu-
ous presence of colchicine [15,20-22]. Cells were seeded
at 1 × 10
4 cells/ml/well in 24 well tissue culture plates
for various studies. One day after seeding, the medium
was removed and fresh medium with/without various
fatty acids, and other compound solutions was added
depending on the experimental protocol. The fatty acids
were initially dissolved in 95% ethanol and the final con-
centration of ethanol was not more than 0.02% in all
control and fatty acid supplemented cultures.
Cell viability studies
KB-3-1 and KB-Ch
R-8-5 cells treated with various fatty
acids and other compounds were also assessed for their
viability at the end of various incubation periods. The
viability of cells was assessed by using Trypan blue dye
exclusion method.
Thymidine incorporation studies
To study the growth of KB-3-1 and KB-Ch
R-8-5 cells in
the presence of various concentrations of different fatty
acids and the effect of cyclo-oxygenase (CO) and lipoxy-
genase (LO) inhibitors, anti-oxidants and calmodulin
antagonists, the ability of cells to incorporate radiola-
beled thymidine as a function of DNA synthesis was
used. One day after seeding, 0.5 μCi of labeled thymi-
dine (specific activity 18, 500 mCi/mmol) was added 6
hours before harvesting the cells. At the end of the
incubation period, the cells were washed at least three
times with PBS (pH 7.4), detached by trypsinization,
extracted for DNA, and counted in a liquid scintillation
counter on days 1, 2 and 3 to assess cell growth.
NBT reduction
T h es u p e r o x i d ea n i o n( O 2
.-) can reduce nitroblue tetra-
zolium (NBT) ion to the insoluble formazan. This is a
simple, reliable and acceptable method of assaying
superoxide anion and possibly, other free radicals
[1,18-21]. KB-3-1 and KB-Ch
R-8-5 cells grown with or
without fatty acids, with or without other compounds
for 24, 48 a 72 hours were checked for their ability to
reduce NBT by incubation with 0.1% NBT dissolved in
phosphate buffered saline (pH 7.4) for 2 hours at the
end of each time period. Termination of the assay (final
assay volume 0.3 ml) was done by adding 0.6 ml of gla-
cial acetic acid into which the reduced NBT dye was
extracted and read at 560 nm as described previously
[1,23-25].
Hydrogen peroxide formation
The amount of H2O2 formed in KB-3-1 and KB-Ch
R-8-5
cells with and without fatty acid treatment and other
compounds was estimated by the horse-radish peroxi-
dase method [26-28].
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The total amount of lipid peroxidation products formed
in the cells was estimated using the thiobarbituric acid
(TBA) method [29,30].
Uptake of radiolabeled vincristine
The uptake of radiolabeled vincristine was studied using
3H-vincristine sulfate (specific activity 6.2 Ci mmol
-1).
To 1 × 10
4 cells/ml/well, one day after seeding, the
medium was replaced with fresh medium along with 50
nm [
3H] vincristine was added and incubated for further
tile periods. At the end of 1, 2, 4, 6 and 12 hours of
addition of vincristine, the cells were washed, detached
by trypsinization and counted in a liquid scintillation
counter. To study the effect of fatty acids on vincristine
uptake, one day after seeding KB-3-1 and KB-Ch
R-8-5
cells were incubated with different doses of fatty acids
ranging from 10 to 40 μg/ml. After 6 hours of addition
of fatty acids, 50 nm of [
3H] vincristine was added and
incubated for further time periods. At the end of 1, 2
and 4 hours of radiolabeled vincristine addition; cells
were washed thrice with PBS, detached by trypsinization
and counted in a liquid scintillation counter.
All the experiments were performed in quadruplicate
and repeated at least twice. Result are expressed as
Mean ± SD and analyzed using Student’s t test and/or
o n e - w a sa n a l y s i so fv a r i a n c ef o l l o w e db yT u k e y ’sH o n -
esty Significant Difference (HSD) test.
Efflux of [
3H] vincristine in the presence of fatty acids
1×1 0
4 cells/ml/well were seeded in 24-well plates. Cells
were allowed to attach to plastic overnight and at the
end of 24 hours, medium was aspirated and fresh med-
ium added along with fatty acids whose concentrations
ranged from 5-40 μg / m l .A tt h ee n do f4h o u r so ff a t t y
acid incubation, 50 nM [
3H] vincristine was added and
incubated for another 2 hours after which the medium
was discarded and cells were washed with PBS. 0.5 ml
of phenol red free DMEM was added to the cells and
i n c u b a t e df o r1 ,2a n d4h o u r s .A tt h ee n do ft h ei n c u -
bation period, the medium was aspirated and counted in
a liquid scintillation counter.
Uptake of radiolabeled fatty acids
The uptake of radiolabeled fatty acids (ALA, AA and
EPA) was studied using
14C-labeled ALA, AA and EPA
(specific activity 54, 55, 59 mCi/mmol). To 1 × 10
4
cells/ml/well, one day after seeding, the medium was
replaced with fresh medium along with 50 nm [
14C] of
respective fatty acid was added and incubated for further
tile periods. At the end of 6, 12, 24, 28, and 72 hours of
addition of fatty acid, the cells were washed, detached
by trypsinization and counted in a liquid scintillation
counter.
Efflux of [
14C] fatty acids by vincristine-sensitive (KB-3-1)
and vincristine-resistant (KB-Ch
R-8-5) cells
1×1 0
4 cells/ml/well were seeded in 24-well plates. Cells
were allowed to attach to plastic overnight and at the
end of 24 hours, medium was aspirated and fresh med-
ium added along with labeled fatty acids. At the end of
6, 12, 24, 48, and 72 hours4 hours of labelled fatty acid
incubation, the medium was aspirated and counted in a
liquid scintillation counter.
Statistics
All the experiments were performed in quadruplicate
and repeated at least twice. Result are expressed as
Mean ± SD and analyzed using Student’s “t” test and/or
o n e - w a sa n a l y s i so fv a r i a n c ef o l l o w e db yT u k e y ’sH o n -
esty Significant Difference (HSD) test depending on the
experimental protocols.
Results
Effect of various fatty acids on the survival of vincristine-
sensitive and resistant tumor cells in vitro
Results shown in Figure 1 clearly indicate that KB-Ch
R-8-
5 cells are resistant to the cytotoxic action of vincristine
whereas KB-3-1 cells are more sensitive to its action.
T h ed a t ai nF i g u r e2s h o w st h a tD H A ,E P Aa n dA A
are the most effective of all the fatty acids tested with
regard to their cytostatic/toxic effects on KB-3- and KB-
ChR-8-5 cells. The cytostatic/cytotoxic effect of various
fatty acids tested is further evident from the thymidine
incorporation studies given in Figures 3, 4, 5 and 6.
These results showed that thymidine incorporation
decreases as the dose of fatty acids is increased. The
cytostatic/cytotoxic action of fatty acids on KB-3-1 cells
in order of potency is as follows: DHA > EPA > GLA =
DGLA > AA > LA > ALA. On the other hand, the cyto-
static/cytotoxic action of fatty acids on KB-Ch
R-8-5, the
Figure 1 Effect of various concentrations of vincristine on the
survival of vincristine sensitive (KB-3-1) and resistant (KB-Ch
R-
8-5) tumor cells in vitro expressed as percentage of control. All
values are Mean ± SD.
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lows: DHA > AA > DGLA = EPA = GLA > LA > ALA.
These results indicate that both vincristine-sensitive and
resistant cells are almost equal in their sensitivity to the
cytotoxic action of various fatty acids tested.
Effect of CO, LO inhibitors, anti-oxidants and calmodulin
antagonists on the cytotoxic action of polyunsaturated
fatty acids
Since polyunsaturated fatty acids (PUFAs) form precur-
sors to various prostaglandins (PGs), leukotrienes (LTs)
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Figure 2 Effect of different doses of n-6 and n-3 fatty acids on the survival of vincristine-sensitive (KB-3-1) and vincristine-resistant (K-
B-Ch
R-8-5) tumor cells in vitro on day 3 expressed as percentage of control. All values are Mean ± SD.
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radicals and modulate the action of calmodulins, the
possibility that the fatty acids tested are able to bring
about their cytotoxic action on KB-3-1 cells based on
these mechanisms was tested using CO and LO inhibi-
tors, various anti-oxidants and calmodulin antagonists.
The results of this study done with GLA and DHA as
representative of n-6 and n-3 fatty acids given in Figures
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Figure 3 Effect of different doses of LA and GLA on thymidine uptake by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-
Ch
R-8-5) tumor cells in vitro on days 1-3 expressed as percentage of control. All values are Mean ± SD.
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NDGA, a LO inhibitor, were ineffective in blocking the
cytotoxic action of GLA and DHA.
It is evident from the results shown in Figure 8 that both
indomethacin and NDGA, a CO and LO inhibitors respec-
tively, were ineffective in blocking the cytotoxic action of
GLA on KB-3-1 cells in vitro. Both vitamin E and SOD
completely blocked the cytotoxic action of GLA on KB-3-
1 cells, while synthetic anti-oxidants such as BHA and
BHT and calmodulin antagonists: chlorpromazine (CPZ)
and trifluoperazine (TFP) were ineffective. On the other
hand, both mannitol and catalase were effective in
Figure 4 Effect of different doses of DGLA and AA on thymidine uptake by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-
Ch
R-8-5) tumor cells in vitro on days 1-3 expressed as percentage of control. All values are Mean ± SD.
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60%. These results are more evident by day 3.
Similar to the results seen with GLA, even with DHA
it is clear from the results shown in Figure 8 that both
indomethacin and NDGA, a CO and LO inhibitors
respectively, were ineffective in blocking the cytotoxic
action of DHA on KB-3-1 cells in vitro. Both vitamin E
and SOD completely blocked the cytotoxic action of
Figure 5 Effect of different doses of ALA and EPA on thymidine uptake by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-
Ch
R-8-5) tumor cells in vitro on days 1-3 expressed as percentage of control. All values are Mean ± SD.
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as BHA and BHT and calmodulin antagonists: chlorpro-
mazine (CPZ) and trifluoperazine (TFP) were ineffective.
On the other hand, unlike the results seen with GLA,
both mannitol and catalase were as effective as that of
vitamin E and SOD in inhibiting the DHA-induced
cytotoxicity. These results are more evident on day 3.
Effect of PUFAs on free radical generation by KB-3-1 and
KB-Ch
R-8-5 cells in vitro
Since vitamin E and SOD (superoxide dismutase), an
effective anti-oxidant and a superoxide quencher respec-
tively, blocked the cytotoxic action of fatty acids on KB-
3-1 and KB-Ch
R-8-5 cells, and since free radical genera-
tion can be modulated by fatty acids, the effect of
various n-6 and n-3 fatty acids on superoxide anion and
H2O2 generation and the formation of lipid peroxides in
these cells was studied. The results shown in Figures 9,
10, 11, 12, 13 and 14 indicate that although all the fatty
acids are effective, relatively higher amounts of superox-
ide and H2O2 generation and formation of lipid perox-
ides were observed in GLA, AA, EPA and DHA-treated
KB-3-1 and KB-Ch
R-8-5 cells. It is noteworthy that
enhanced generation of superoxide anion, H2O2 and
lipid peroxides induced by GLA, AA, EPA and DHA
corresponded to their cytotoxic action on KB-3-1 and
KB- Ch
R-8-5 cells.
It is interesting to note that NBT reduction reaction
(that detects superoxide anion generation) induced by
fatty acids could be completely blocked by SOD suggest-
ing that under the conditions employed, what is being
measured, in fact, is the superoxide anion radical. The
involvement of free radicals and lipid peroxides in the
fatty acid-induced cytotoxicity is supported by the
observation that both free radical generation and the
formation of lipid peroxidation products (measured as
MDA-reactive material) in KB-3-1 cells can be comple-
tely inhibited by vitamin E and SOD. This experiment
was performed with 40 μg/ml of GLA, EPA and DHA
fatty acids in KB-3-1 cells and the results are given in
Figure 15.
Uptake and efflux of radiolabeled vincristine in KB-3-1
and KB-Ch
R-8-5 cells in vitro
In order to understand the mechanism as to why KB-3-
1 cells are sensitive whereas KB-Ch
R-8-5 cells are resis-
tant to the cytotoxic action of vincristine, the uptake
and efflux of radiolabeled vincristine in these cells was
studied. The results shown in Figure 16 revealed that
the uptake of vincristine is almost 4 to 5-fold higher in
KB-3-1 cells compared with the uptake by KB-Ch
R-8-5
cells. On the other hand, the efflux of vincristine is 1 1/
2 to 3 times less in KB-3-1 cells compared with the
efflux shown by KB-Ch
R-8-5 cells. This difference in the
uptake and efflux ultimately resulted in 2-3 fold higher
concentration of vincristine in KB-3-1 cells compared to
KB-Ch
R-8-5 cells. This higher intracellular concentration
of vincristine in KB-3-1 cells could be responsible for
their sensitivity to the cytotoxic action of vincristine,
whereas KB-Ch
R-8-5 cell are resistant to the cytotoxic
action of vincristine since they are able to effectively
reduce the intracellular concentration of vincristine by
an effective efflux pump. Thus, the uptake of vincristine
is high in KB-3-1 cells and the efflux of the drug is
minimal while vincristine- resistant KB-Ch
R-8-5 cells
showed minimal uptake and very effective efflux
mechanism to remove vincristine from within the cell.
As a result, the accumulation of vincristine is not seen
in resistant cells KB-Ch
R-8-5 cells.
Figure 6 Effect of different doses of DHA on thymidine uptake
by vincristine-sensitive (KB-3-1) and vincristine-resistant (K-B-
Ch
R-8-5) tumor cells in vitro on days 1-3 expressed as
percentage of control. All values are Mean ± SD.
Figure 7 Effect of various anti-oxidants, cyclo-oxygenase and
lipoxygenase inhibitors and calmodulin antagonists on
thymidine incorporation in KB-3-1 cells in vitro on day 1, 2 and
3. All values are Mean ± SD.
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and efflux of drugs, it is expected that supplementation
of PUFAs that get incorporated into the cell membrane
lipids to vincristine-resistant cells may render them
sensitive to the cytotoxic action of vincristine by enhan-
cing its uptake and reducing the efflux. Studies per-
formed to verify this possibility showed that this is
indeed the case as presented below.
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Figure 8 Effect of various anti-oxidants, cyclo-oxygenase and lipoxygenase inhibitors and calmodulin antagonists on GLA and DHA-
induced growth inhibition of KB-3-1 cells in vitro.
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Figure 9 Effect of various n-6 and n-3 fatty acids on the amount of superoxide anion generated in KB-3-1 cells measured as NBT
reduction and expressed as μ moles of diformazan formed in vitro. All values are Mean ± SD. * P < 0.05 compared to control.
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Figure 10 Effect of various concentrations of different n-6 and n-3 fatty acids on the generation of H2O2 by KB-3-1 cells in vitro.A l l
values are expressed as μ moles of H2O2 formed. All values are Mean ± SD. * P < 0.05 compared to control.
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Figure 11 Effect of different doses of n-6 and n-3 fatty acids on the formation of lipid peroxides (expressed as pmoles of MDA-eq
formed) in KB-3-1 cells in vitro. All values are Mean ± SD. *P < 0.05 compared to control.
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Page 12 of 35Figure 12 Effect of various n-6 and n-3 fatty acids on the amount of superoxide anion generated in KB-Ch
R-8-5 measured as NBT
reduction and expressed as μ moles of diformazan formed in vitro. All values are Mean ± SD. * P < 0.05 compared to control.
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Figure 13 Effect of various n-6 and n-3 fatty acids on the amount of hydrogen peroxide generated in KB-Ch
R-8-5 in vitro. All values are
Mean ± SD. * P < 0.05 compared to control.
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Figure 14 Effect of different doses of n-6 and n-3 fatty acids on the formation of lipid peroxides (expressed as pmoles of MDA-eq
formed) in KB-Ch
R-8-5 cells in vitro. All values are Mean ± SD. * P < 0.05 compared to control.
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3H] vincristine by KB-3-1 and KB-
Ch
R-8-5 cells in the presence of various fatty acids
Effect of various n-6 fatty acids
Studies with LA In the presence of various n-6 fatty
acids such as LA, GLA, DGLA and AA the uptake and
efflux of radiolabeled vincristine was substantially
altered. When KB-3-1 cells were incubated for different
time intervals with LA there was no significant change
in the uptake and efflux of vincristine as shown in Fig-
ure 17. Both uptake and efflux of vincristine by KB-3-1
cells were almost similar that resulted in no significant
increase in accumulation of vincristine in the cells. This
suggests that LA is unlikely to enhance the cytotoxic
action of vincristine when both are added together to
the tumor cells. In a similar fashion, LA did not sub-
stantially enhance the accumulation of vincristine in
drug-resistant cells KB-Ch
R-8-5 cells since both the
uptake and efflux of vincristine were almost similar (see
Figure 17).
Studies with GLA Unlike LA, GLA was effective in
increasing the uptake of vincristine by 1.5 to 2-fold in
both KB-31 and KB-Ch
R-8-5 cells as shown in Figure
18.
Studies with DGLA S i m i l a rt oG L A ,D G L Aw a sa l s o
effective in enhancing the uptake of vincristine and
reducing the efflux resulting in enhanced intracellular
concentration of the anti-cancer drug. But DGLA was
definitely much less effective compared to GLA. The
results of the studies done with DGLA are given in Fig-
ures 19. It may be noted that GLA is much more effec-
tive against KB-Ch
R-8-5 (vincristine-resistant cells)
compared to DGLA in increasing the uptake of vincris-
tine. Thus, GLA is more effective than DGLA both in
enhancing the uptake of vincristine in KB-Ch
R-8-5 cells
and reducing its efflux. This suggests that GLA may be
more effective in sensitizing the vincristine-resistant
cells to the cytotoxic action of vincristine compared to
DGLA. Since both GLA and DGLA contain 3 double
bonds (GLA = 18:3 while DGLA is 20:3), it appears as
though the number of double bonds may not be respon-
sible for this property (namely, uptake and efflux of vin-
cristine by KB-Ch
R-8-5 cells) shown by the cells. It
could be attributed to the number of carbon atoms.
Studies with AA It is seen from the results shown in
Figure 20 that AA is more effective than GLA and
DGLA in enhancing the uptake and decreasing the
efflux of vincristine by both the vincristine-sensitive
(KB-3-1) and vincristine-resistant (KB-Ch
R-8-5) cells.
Since AA is more unsaturated and contain 20 carbon
atoms (AA = 20:4), it appears as though both the chain
length and unsaturation may contribute to the ability of
the AA in enhancing the vincristine drug uptake and
decrease in its efflux (vincristine) by tumor cells that
could result in higher intracellular concentration(s) of
the anti-cancer drug in drug-sensitive and drug-resistant
cancer cells.
Effect of various n-3 fatty acids
Studies with ALA Similar studies were also performed
with n-3 fatty acids: ALA, EPA and DHA. It is evident
from these results shown in Figures 21, 22 and 23 that
Figure 15 Effect of anti-oxidants vitamin E and SOD
(superoxide dismutase) on the generation of free radicals
(superoxide anion) and lipid peroxides induced by GLA, EPA
and DHA in KB-3-1 cells in vitro on day 3 of incubation with
fatty acids. Superoxide anion generated in KB-3-1 cells was
measured as NBT reduction (expressed as μ moles of diformazan
formed) and lipid peroxides formed is measured by TBA reaction
and expressed as pmoles of MDA-eq formed. All studies were done
on day 3 following incubation with 40 μg/ml of fatty acids with or
without vitamin E or SOD. All values are Mean ± SD. * P < 0.05
compared to control; #P < 0.05 compared to fatty acid treatment.
Figure 16 Uptake and efflux of vincristine (radiolabeled) by
vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-Ch
R-8-
5) tumor cells in vitro at different time intervals.
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Page 16 of 35similar to LA, ALA is not effective in enhancing the
uptake and decreasing the efflux of vincristine by KB-3-
1a n dK B - C h
R-8-5 cells; whereas EPA (n-3, 20:5) and
DHA (n-3, 22:6) significantly enhanced uptake and
decreased efflux of vincristine by KB-3-1 and KB-Ch
R-8-
5 cells such that the intracellular concentrations of the
anti-cancer drug is increased leading to death of the
tumor cells. Of all the three n-3 fatty acids tested DHA
 
Figure 17 Uptake and efflux of [
3H] vincristine by vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-Ch
R-8-5) tumor cells in
vitro in the presence of LA. All values are shown as % of the control.
Das and Madhavi Lipids in Health and Disease 2011, 10:159
http://www.lipidworld.com/content/10/1/159
Page 17 of 35is the most effective followed by EPA while ALA is the
least effective or has no effect (DHA > EPA > ALA). In
addition both n-6 and n-3 fatty acids were more effec-
tive at higher concentrations (say 20 and 40 μg) while
they were less effective at lower doses (5-10 μg). In gen-
eral, GLA, AA, EPA and DHA were more effective in
enhancing the uptake of vincristine but had a small
effect in decreasing the efflux of the drug both in the
 
Figure 18 Uptake and efflux of [
3H] vincristine by vincristine-resistant (KB-Ch
R-8-5) tumor cells in vitro i nt h ep r e s e n c eo fG L A .A l l
values are expressed as % of control.
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Page 18 of 35KB-3-1 and KB-Ch
R-8-5 cells. This suggests that GLA,
AA, EPA and DHA are more effective in enhancing the
uptake of the anti-cancer drugs and had less effect in
decreasing the efflux of the drugs. Nevertheless, GLA,
AA, EPA and DHA effectively increased intracellular
concentration of vincristine, an action that seems to be
responsible for the augmentation of the cytotoxic action
of anti-cancer drugs by PUFAs.
Effect of combined action of sub-optimal concentrations
of vincristine and sub-optimal doses of PUFAs on KB-Ch
R-
8-5 cells in vitro
If it is true that fatty acids are able to enhance the uptake
and decrease the efflux of anti-cancer drugs, then it is
anticipated that a combination of sub-optimal doses of
anti-cancer drugs and sub-optimal doses of fatty acids
could induce substantial cytotoxic action on tumor cells.
Hence, studies were performed on the cytotoxic action of
a combination of sub-optimal doses of vincristine and
sub-optimal doses of fatty acids on their cytotoxic action
on vincristine-resistant (KB-Ch
R-8-5) cells in vitro.
In this study, KB-Ch
R-8-5 (vincristine-resistant tumor)
cells were exposed to sub-optimal doses of vincristine
and sub-optimal doses of various n-6 and n-3 PUFAs.
The results of these studies given in Figures 24, 25, 26,
2 7a n d2 8s h o w e dt h a tw h e nK B - C h
R-8-5 cells were
exposed to 5 nm and 10 nm of vincristine and 5 μg and
10 μg of various fatty acids did not show any substantial
increase in the number of dead cells compared to the
control. Thus, 5 nm and 10 nm of vincristine and 5 μg
and 10 μg of fatty acids when used alone could be con-
sidered as sub-optimal doses at which there is no
increase in the number of dead cells in comparison to
control.
On the other hand, when KB-Ch
R-8-5 cells were
exposed to a combination of sub-optimal doses of vin-
cristine and various n-6 and n-3 fatty acids, a significant
increase in the number of dead cells was observed. Of
all the fatty acids tested, GLA, DGLA, AA, EPA and
DHA were found to be the most effective in enhancing
the cytotoxicity of sub-optimal doses of vincristine. LA
was found to the least effective whereas ALA was effec-
tive only to a limited extent in enhancing the cytotoxi-
city of sub-optimal doses of vincristine. These results
suggest that a combination of sub-optimal doses of vin-
cristine and GLA, DGLA, AA, EPA and DHA fatty acids
are effective in substantially enhancing the death of vin-
cristine-resistant (KB-Ch
R-8-5) tumor cells in vitro.
For easy understanding, a summary of the results
obtained with sub-optimal doses of n-6 and n-6 fatty
acids (10 μg of fatty acids) and vincristine (10 nm) is
given in Figure 28.
It is evident from the results shown in Figures 24, 25,
26, 27 and 28 that there is a gradual enhancement in
the cytotoxic action of sub-optimal doses of a combina-
tion of vincristine and fatty acids as given below:
Fatty acid 5 μg + Vincristine 5 nm < Fatty acid 10 μg
+ Vincristine 5 nm < Fatty acid 5 μg+V i n c r i s t i n e1 0
nm < Fatty acid 10 μg + Vincristine 10 nm.
Thus, the most effective sub-optimal doses of vincris-
tine and fatty acid in inducing the death of vincristine-
resistant cells is vincristine 10 nm + fatty acid 10 μg. Of
all the fatty acids tested, the most effective fatty acid is
DHA. With regard to the fatty acids, the effectiveness of
the fatty acids when used at sub-optimal doses in com-
bination with vincristine is as follows: DHA > GLA >
AA = EPA.
Uptake and efflux of fatty acids by vincristine-sensitive
and vincristine-resistant cells in vitro
It is evident from the results shown in Figures 16, 17,
18, 19, 20, 21, 22 and 23 that the uptake and efflux of
vincristine by vincristine-sensitive (KB-3-1) and vincris-
tine-resistant (KB-Ch
R-8-5) cells is modified by various
n-6 and n-3 fatty acids. GLA, AA, EPA and DHA
enhanced the uptake of vincristine and reduced its efflux
in these two cell lines. As a result, the intracellular
 
Figure 19 Uptake and efflux of [
3H] vincristine by vincristine-
sensitive (KB-3-1) tumor cells in vitro in the presence of DGLA.
All values are expressed as % of control.
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Page 19 of 35concentration of vincristine is enhanced resulting in
apoptosis of tumor cells. Thus, GLA, AA, EPA and
DHA are capable of augmenting the apoptosis of both
vincristine-sensitive and vincristine-resistant cells to
vincristine. But, no data is available as to the uptake and
efflux of fatty acids themselves in KB-3-1 and KB-Ch
R-
8-5 cells. Hence, we studied the uptake and efflux of
fatty acids in these two cell lines.
 
Figure 20 Uptake and efflux of [
3H] vincristine by vincristine-sensitive (KB-3-1) tumor cells in vitro in the presence of AA. All values are
expressed as % of control.
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Page 20 of 35The results of this study given in Figures 29 and 30,
suggest that the uptake of fatty acids is higher and the
efflux is lower in KB-3-1 cells compared to the uptake
and efflux of the same fatty acids in KB-Ch
R-8-5 cells.
This could be one reason for the higher sensitivity of
KB-3-1 cells to the cytotoxic action of fatty acids com-
pared to KB-Ch
R-8-5 cells. Of the three fatty acids
tested, the uptake and efflux of DHA = AA > ALA both
in KB-3-1 and KB-Ch
R-8-5 cells.
Discussion
Previous studies showed that PUFAs such as GLA,
AA, EPA and DHA have tumoricidal action (1-6,
[31-36], for metabolism of essential fatty acids, EFAs,
and see Figure 31). This tumoricidal action of fatty
acids seems to depend on their ability to augment
free radical generation and lipid peroxidation process
in the tumour cells [1,4,5,13,25]. The involvement of
free radicals is supported by the observation that
 
Figure 21 Uptake and efflux of [
3H] vincristine by vincristine-sensitive (KB-3-1) and vincristine-resistant (KB-Ch
R-8-5) tumor cells in
vitro in the presence of ALA. All values are % of control.
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Page 21 of 35antioxidants such as vitamin E, superoxide dismutase
(SOD) and to some extent BHA and BHT (butylated
hydroxy anisole and butylated hydroxytoluene, respec-
tively) can prevent the tumoricidal action of PUFAs
[ 1 ,4 ,1 3a n dt h ep r e s e n ts t u d y ] .B o t hf r e er a d i c a l s
and lipid peroxides induce damage to a variety of
enzymes, proteins and DNA and thus, lead to cell
death [37]. Further free radicals deplete ATP levels in
 
Figure 22 Uptake and efflux of [
3H] vincristine by vincristine-sensitive (KB-3-1) vincristine-resistant (KB-Ch
R-8-5) tumor cells in vitro in
the presence of EPA. All values are % of control.
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Page 22 of 35the cells and cause apoptosis [38-40]. Since PUFAs
enhance free radical generation and lipid peroxidation
process and thus, induce apoptosis, it suggests that
these events lead to depletion of ATP levels in the
tumor cells which leads to their death. This implies
that an interaction exists among fatty acids, lipid
peroxidation process, apoptosis and genes/oncogenes
that regulate apoptotic process [12].
In this context, it is important to note that reactive
oxygen metabolite hydrogen peroxide (H2O2)s t i m u l a t e s
A Ar e l e a s ea n dt h r o m b o x a n eA 2 (TXA2) synthesis in
the rat alveolar macrophage, but does not stimulate 5-
 
Figure 23 Uptake and efflux of [
3H] vincristine by vincristine-sensitive (KB-3-1) vincristine-resistant (KB-Ch
R-8-5) tumor cells in vitro in
the presence of DHA. All values are % of control.
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Page 23 of 35lipoxygenase metabolism to form leukotriene B4 (LTB4),
LTC4, or 5-hydroxyeicosatetraenoic acid (5-HETE).
H2O2 dose-dependently inhibited synthesis of LTB4,
LTC4, and 5-HETE induced by the agonists A23187 (10
microM) and zymosan (100 micrograms/ml), over the
same concentration range at which it augmented synth-
esis of the cyclooxygenase products TXA2 and 12-
hydroxy-5,8,10-heptadecatrienoic acid. This action of
 
Figure 24 Effect of sub-optimal doses of LA and GLA and vincristine on the proliferation of vincristine-resistant (KB-Ch
R-8-5) tumor
cells in vitro. All values are mean ± SE. In the study with sub-optimal doses of GLA, *P < 0.05 compared to control (vincristine 5 nm and 10
nm and GLA 5 μg/ml and 10 μg/ml).
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Page 24 of 35H2O2 on 5-lipoxygenase and cyclo-oxygenase synthesis
is due to the ability of H2 O2 to deplete cellular ATP, a
cofactor for 5-lipoxygenase. Thus, H2O2 can act both as
an agonist for macrophage AA metabolism, and as a
selective inhibitor of the 5-lipoxygenase pathway by its
ability to deplete ATP [40]. These results are interesting
in the light of the observation that LTs enhance the
growth of tumor cells [41,42]. This can be interpreted
 
Figure 25 Effect of sub-optimal doses of DGLA and AA and vincristine on the proliferation of vincristine-resistant (KB-Ch
R-8-5) tumor
cells in vitro. All values are expressed as Mean ± SE. *P < 0.05 compared to control (vincristine and DGLA and AA alone controls).
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Page 25 of 35to mean that free radicals, especially H2O2, induce apop-
tosis of tumor cells by depleting the cells (a) of their
ATP content, and (b) of LTs that are tumor growth pro-
moters by selectively inhibiting 5-lipoxygenase activity
[43,44]. But, this growth inhibitory action of LTs is not
without controversy since some studies did suggest that
LTB4 and LTC4 m a yh a v et u m o rg r o w t hi n h i b i t o r y
actions [45,46]. These controversial results could be due
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Figure 26 Effect of sub-optimal doses of ALA, EPA and vincristine on the proliferation of vincristine-resistant (KB-Ch
R-8-5) tumor cells
in vitro. All values are mean ± SE. *P < 0.05 compared to control.
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Page 26 of 35to the differences tumor cell lines studied and the doses
of LTs employed.
In the light of these evidences, the result of the pre-
sent study wherein it is noted that GLA, AA, EPA and
DHA are cytotoxic to both vincristine-sensitive and
resistant tumor cells is interesting. The inability of both
indomethacin and NDGA, a CO and LO inhibitors
respectively, to block, while the ability of vitamin E and
SOD to completely inhibit the cytotoxic action of GLA
and DHA on KB-3-1 cells suggested that in all
probability PGs, LTs and TXs do not participate in the
cytotoxic action of PUFAs. It is possible that KB-3-1
cells and possibly. KB-Ch
R-8-5 cells do not form signifi-
cant amounts of LTs that are known to enhance the
growth of tumor cells [41,42]. The failure of calmodulin
antagonists: chlorpromazine (CPZ) and trifluoperazine
(TFP) to block the cytotoxic action of PUFAs indicates
that calmodulin does not play a role in the proliferation
of KB-3-1 and KB-Ch
R-8-5 cells. Though antioxidant
vitamin E completely blocked the cytotoxic action of
PUFAs (GLA, AA, EPA and DHA), failure of BHA and
BHT, synthetic antioxidants, to show similar inhibitory
action is rather surprising. This may mean that the free
radicals that are scavenged by vitamin E and BHA and
BHT are different and/or act on the free radical-
mediated cellular processes in vastly different manner(s).
Both mannitol and catalase were partially effective in
inhibiting the GLA- and DHA-induced cytotoxicity (Fig-
ure 8) suggesting that there is only partial involvement
of hydroxyl radical and H2O2 respectively in their cyto-
toxic action [47]. On the other hand, vitamin E comple-
tely blocked the cytotoxic actions of GLA, AA, EPA and
DHA on both vincristine-sensitive and resistant cells by
suppressing free radical generation in these cells (Figure
15). The ability of vitamin E but not of synthetic antiox-
idants BHA and BHT and only partial inhibition by cat-
alase and mannitol suggests that, perhaps, all types of
free radicals (superoxide anion, H2O2, hydroxyl radicals)
and lipid peroxides play a role in the induction of apop-
tosis of tumor cells by PUFAs. The potent action of
vitamin E in the inhibition of PUFA-induced tumoricidal
action could also be attributed to its lipid soluble nature,
its ability to protect glutathione against microsomal lipid
peroxidation [48] and block lipid peroxidation chain
reaction [49]. As a result of these actions, vitamin E is
able to remove free radical intermediates and prevent
the oxidation reaction from continuing. This is sup-
ported by the observation that vitamin E prevented
PUFA-induced free radical generation and formation of
lipid peroxides in vincristine-sensitive cells (Figure 15).
Since drug-resistance is a major issue in clinical prac-
tice, we studied whether PUFAs have the ability to alter
the sensitivity of vincristine-resistant cells to the cyto-
toxic action of vincristine in vitro. Based on the results
obtained in the present study, it is clear that certain
PUFAs are not only capable of selectively killing the
tumor cells with little effect on normal cells at the con-
centrations tested but are also capable of enhancing the
uptake of anti-cancer drugs both by drug-sensitive and
drug-resistant tumor cells (see Figures 17, 18, 19, 20, 21,
22 and 23) and may reverse tumor cell drug resistance
in vitro.T h u s ,G L A ,A A ,E P Aa n dD H Aa r ea b l et o
bring about their tumoricidal action (i) by enhancing
free radical generation and lipid peroxidation process in
Figure 27 Effect of sub-optimal doses of DHA and vincristine
on the proliferation of vincristine-resistant (KB-Ch
R-8-5) tumor
cells in vitro. P < 0.05 compared to control.
Figure 28 Effect of sub-optimal doses of n-6 and n-3 fatty
acids (10 μg of fatty acids) and vincristine (10 nm) on the
proliferation of vincristine-resistant (KB-Ch
R-8-5) tumor cells in
vitro. * P < 0.05 compared to control.
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Page 27 of 35tumor cells and (ii) by increasing intracellular concen-
tration of the anti-cancer drugs.
These results are further supported by the observation
that when sub-optimal doses of vincristine and PUFAs
are used, the cytotoxic action of vincristine was substan-
tially enhanced especially by GLA, DGLA, AA, EPA and
DHA (Figures 24, 25, 26, 27 and 28). In addition, uptake
of PUFAs is higher in vincristine-sensitive cells
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Figure 29 Uptake and efflux of labeled fatty acids (ALA, AA, EPA) by vincristine-sensitive (KB-3-1) vincristine-resistant (KB-Ch
R-8-5)
cells in vitro at different time intervals.
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Page 28 of 35compared to vincristine-resistance cells while the efflux
is higher in the vincristine-resistant cells compared with
vincristine-sensitive cells (Figures 29 and 30). These
results indicate that, in general, drug-resistant cells
show higher efflux compared to drug-sensitive tumor
cells not only to anti-cancer drugs but also to PUFAs
whereas drug-sensitive cells show higher uptake and
decreased efflux to anti-cancer drugs and PUFAs
 
Figure 30 A comparison of the uptake and efflux of fatty acids (ALA, AA, EPA) by vincristine-sensitive (KB-3-1) vincristine-resistant
(KB-Ch
R-8-5) cells in vitro at different time intervals.
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Page 29 of 35(Figures 17, 18, 19, 20, 21, 22 and 23 and Figures 29 and
30). These studies imply that PUFAs could be used to
reduce drug-resistance or reverse drug-resistance by var-
ious tumor cells such that chemotherapeutic drugs
could bring about their tumoricidal action more
effectively.
Previous studies [1-5,11,14] suggested that PUFAs (if
not all at least GLA, AA, EPA and DHA) have differen-
tial toxicity towards normal and tumor cells indicating
that normal and tumor cells metabolize fatty acids dif-
ferentially. For instance, AA is metabolized to produce
the 5-lipoxygenase metabolite, 5-HETE (5-hydroxyeico-
satetraenoic acid) by prostate cancer cells that
stimulated their growth, suggesting that 5-HETE is a
survival factor for these cells. Prostate cancer cells con-
stitutively produce 5-HETE and exogenous arachidonate
markedly increases the production of 5-HETE, while
inhibition of 5-lipoxygenase induced apoptosis in both
hormone-responsive (LNCaP) and -nonresponsive (PC3)
human prostate cancer cells. Apoptosis was specific for
5-lipoxygenase-programmed cell death since it was not
observed with inhibitors of 12-lipoxygenase, cyclooxy-
genase, or cytochrome P450 pathways of AA metabo-
lism. Exogenous 5-HETE protected these cells from
apoptosis induced by 5-lipoxygenase inhibitors, confirm-
ing a critical role of 5-lipoxygenase activity in the
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Page 30 of 35survival of these cells [50]. Hence, it can be said that the
way free fatty acids are metabolized by tumor cells, be
drug-sensitive and drug-resistant cells, influence survival
and progression of cancer. For example, free AA and
GLA are tumoricidal but when AA is converted to form
5-HETE by 5-lipoxygenase, the tumor cells are stimu-
lated to grow [51,52].
Cyclooxygenase-2 (COX-2)i su p - r e g u l a t e di nm a n y
cancers that may explain as to why COX-2 inhibitors
prevent colon cancer. This, in part, could be attributed
to an accumulation of the substrate (AA) or diversion of
the substrate into another pathway. For example, colon
adenocarcinomas overexpress AA-utilizing enzyme, fatty
acid-CoA ligase (FACL) 4, in addition to COX-2. Thus,
unesterified arachidonic acid in cells is a signal for
induction of apoptosis. Tumor cells engineered with
inducible overexpression of COX-2 and FACL4 act as
“sinks” for unesterified AA as evidenced by the observa-
tion that activation of the enzymatic sinks blocked apop-
tosis, and the reduction of cell death was inversely
correlated with the cellular level of AA. Cell death
caused by TNF-a is prevented by removal of unesteri-
fied AA, suggesting that cellular level of unesterified AA
and other unsaturated fatty acids is a general mechan-
ism by which apoptosis is regulated and that COX-2
and FACL4 promote carcinogenesis by lowering this
level [53-56]. Furthermore,N S A I D su p - r e g u l a t e d1 5 -
LOX-1 and 15-LOX-1 inhibition blocked NSAID-
induced apoptosis, which was restored by 13-S-HODE
(13-S-hydroxyoctadecadienoic acid, is the product of 15-
LOX-1 protein, the other product of 15-LOX-1 is 15-S-
HETE, but in this study 15-S-HETE formation was not
noted) but not by its parent, LA. Thus, NSAIDs induce
apoptosis in colon cancer cells via up-regulation of 15-
LOX-1 in the absence of COX-2 [57-59]. Hydroperox-
ides generated by 5-, 12-, or 15-lipoxygenases from
linoleate, linolenate, or arachidonate (hydroperoxides
may be detected as lipid peroxides by MDA reaction as
was done in the present study), and the corresponding
hydroxides induced apoptosis of erythroleukemia and
neuroblastoma cells in a concentration- and time-depen-
dent manner, while the terminal products of the arachi-
donate cascade (i.e., leukotrienes, prostaglandins and
thromboxanes) were not cytotoxic [60]. These results
are supported by the results of the present study
wherein it is noted that both CO and LO inhibitors did
not block the cytotoxic action of PUFAs. Thus, free
unsaturated fatty acids need to be converted to their
respective hydroxides to bring about their tumoricidal
action. In addition, many AA metabolites serve as
growth signaling molecules. 5-lipoxygenase (5-LO) path-
way metabolite 5(S)-hydrooxyeicosa-6E,8C,11Z,14Z-tet-
raenoic acid (5-HETE) has a growth stimulatory action
on breast cancer cells whereas selective reduction in the
levels of 5-HETE but not cyclooxygenase inhibitors
reduced growth, increased apoptosis, down-regulated
bcl-2, up-regulated bax, and increased G1 arrest. 5-LO
inhibition up-regulated peroxisome proliferator-activated
receptor-a (PPAR-a)a n dP P A R - g expression, and were
growth inhibited when exposed to relevant PPAR ago-
nists. These results suggest that disruption of the 5-LO
signaling pathway mediates growth arrest and apoptosis
in breast cancer cells, partly, by the induction of PPARs
and activation of PPARs with shunted endoperoxides
[61,62]. These results imply that delivery of free unsatu-
rated fatty acids to the tumor cells and generation of
hydroperoxides by 5- 12-, or 15-lipoxygenases from var-
ious PUFAs such as AA, and simultaneous inhibition of
COX-2 enzyme could lead to apoptosis of tumor cells.
In addition, PUFAs suppress fatty acid synthase enzyme
and thus, induce apoptosis of tumor cells [63-69].
Based on the preceding discussion, one intriguing pos-
sibility is that PUFAs are differentially metabolized by
normal and tumor cells and drug-sensitive and drug-
resistant cells (in addition to the differential uptake and
efflux shown by the drug resistant tumor cells). This is
so because PUFAs form precursors to both cytotoxic
and cytoprotective molecules. For instance, as discussed
above, generation of hydroperoxides by 5- 12-, or 15-
lipoxygenases from linoleate, linolenate, or AA have
cytotoxic actions and induce apoptosis of tumor cells. In
contrast, lipoxins, resolvins, and protectins (including
neuroprotectin D1) have cytoprotective properties by
virtue of their anti-inflammatory actions. Thus, it is
likely that when tumor cells are exposed to adequate
amounts of PUFAs cytotoxic metabolites are generated
that induce apoptosis of tumor cells, whereas normal
cells convert PUFAs to cytoprotective molecules such as
lipoxins, resolvins and protectins [70-81]. This is sup-
ported by the observation that DHA is toxic to tumor
cells but protects normal neural cells from stress-
induced apoptosis and is less or not cytotoxic to normal
cells [1,3,11]. DHA induces apoptosis of neuroblastoma
cells due to its conversion to 17-hydroxydocosahexae-
noic acid (17-HDHA) via 17-hydroperoxydocosahexae-
noic acid (17-HpDHA) through 15-lipoxygenase and
autoxidation [82] and as a result tumor cells do not pro-
duce (or form negligible amounts) of the anti-inflamma-
tory lipid mediators such as resolvins and protectins.
17-HpDHA is cytotoxic to tumor cells [70] and DHA
itself could inhibit secretion of PGE2. Thus, the cyto-
toxic action of DHA on neuroblastoma and other tumor
cells could be due to the production of hydroperoxy
fatty acids and restricted production of resolvins and
protectins that are cytoprotective in nature [83-86]. In a
similar fashion, it is possible that when normal cells are
exposed to GLA, AA, and EPA significant amounts of
lipoxins and resolvin and other similar compounds are
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Figure 32 Scheme showing the differential metabolism of PUFAs in normal and tumor cells. Normal cells exposed to anti-cancer drugs
and radiation produce increased amounts of ROS. In response to this, normal cells produce enhanced amounts of lipoxins, resolvins and
protectins from PUFAs that are released by the activation of phospholipase A2. Infiltrating or local leukocytes and macrophages produce
enhanced amounts of IL-6 and TNF-a that, in turn, enhance ROS generation and cause inflammation. If cell stores of PUFAs are adequate,
activation of phospholipase A2 (the type of phospholipase activated in normal and tumor cells may be distinctly different) leads to release of
PUFAs to be converted to lipoxins, resolvins and protectins, which suppress leukocyte and macrophage activation, ROS generation and
inflammation to protect normal cells from apoptosis. In the case of tumor cells, infiltrating leukocytes and macrophages produce enhanced
amounts of IL-6 and TNF-a that produce excess amounts of ROS leading to inflammation. ROS damage DNA and aid in the progression of
cancer. Tumor cells have decreased amounts of PUFAs that get are converted to pro-inflammatory eicosanoids due to activation of COX-2 and
LO and thus, inflammation and cancer growth are perpetuated. Normal cells supplemented with PUFAs produce adequate amounts of lipoxins,
resolvins and protectins that protect them from ROS, suppress inflammation and prevent actions of mutagens and carcinogens. On the other
hand, tumor cells supplemented with PUFAs generate more free radicals, show enhanced lipid peroxidation that lead to apoptosis. Thus, normal
cells exposed to PUFAs produce cytoprotective lipoxins, resolvins and protectins while tumor cells generate toxic hydroperoxy fatty acids.
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tive, prostanoids, leukotrienes, thromboxanes and cyclo-
pentanone prostaglandins and respective hydroperoxy
fatty acids that are toxic. Hence, it is proposed that nor-
mal cells metabolize PUFAs to produce cytoprotective
lipids such as lipoxins, resolvins and protectins while
tumor cells generate toxic hydroperoxy fatty acids [87].
This differential metabolism of PUFAs by normal and
tumor cells may explain why PUFAs are toxic to tumor
but not to normal cells (see Figure 32). The fact that
both CO and LO inhibitors did not inhibit the cytotoxic
action of PUFAs while there is an increase in the forma-
tion of lipid peroxides in the tumor cells suggests that
products other than PGs, LTs and TXs such as hydro-
peroxides (similar to 17-HpDHA) are formed that
induce tumor cell death. In view of this, it would have
been interesting had we measured various hydroperox-
ides, lipoxins, resolvins and protectins that are formed
in tumor cells in the present study. In future, such stu-
dies need to be performed to confirm the proposals
made above.
In summary, results of the present study and previous
reports [1-17] indicate that
(i) free PUFAs and their hydroperoxides are toxic to
tumor cells;
(ii) PUFAs- induced tumoricidal action could be
attributed to their ability to enhance free radical
generation and lipid peroxidation process;
(iii) PUFAs augment uptake and decrease efflux of
anti-cancer drugs and thus, reverse tumor cell drug
resistance;
(iv) Tumor cells have an effective efflux mechanism
to overcome the cytotoxic action of anti-cancer
drugs;
(v) CO and LO metabolites of PUFAs are less toxic
to tumor cells compared to their (PUFAs) peroxides
(measured in the present as total lipid peroxides)
such as hydroperoxides (82);
(vi) Enhanced activity of CO and LO enzymes in
tumor cells may serve as an escape mechanism to
overcome tumoricidal action of free PUFAs;
(vii) A combination of PUFAs and anti-cancer drugs
show enhanced cytotoxicity against tumor cells;
(viii) Normal cells may form enhanced amounts of
cytoprotective molecules such as lipoxins, resolvins
and protectins while tumor cells form cytotoxic lipid
hydroperoxides and other peroxides (a concept that
needs further confirmation); and
(ix) Tumor cell drug resistance could be due to
increased formation of cytoprotective molecules
such as lipoxins, resolvins and protectins, a concept
that needs to be confirmed by further studies (see
Figure 32).
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